Semaglutide Shows Chondroprotective Effects in Osteoarthritis Through Weight Loss-Independent Metabolic Mechanism
Qin et al. demonstrated the chondroprotective effects of semaglutide in obesity-related osteoarthritis. Mechanistically, these effects are independent of body weight loss and involve metabolic…
Read the full articleYou might also wanna read
Semaglutide Could Reverse Your Osteoarthritis | Medical News Bulletin
Did you see the reddit thread with a Judgey Judy getting schooled on why so many people are using GLP-1R agonists? For anyone wondering, thi
GLP-1 Shows Promise for Patients with Advanced Fatty Liver Disease
GLP-1 semaglutide shows improved liver scarring in advanced MASH, early cirrhosis, offering a potential new treatment option in a large glob
Study: GLP-1 drugs like semaglutide linked to lower amputation risk in diabetes patients with peripheral artery disease
A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type 2 diabetes and
medicalnewstoday.com·13d agoStudy: GLP-1 drugs like semaglutide linked to lower amputation risk in diabetes patients with peripheral artery disease
A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type 2 diabetes and
Mnt News·13d ago
EFL071 – Taste Changes with Semaglutide
For our 71st episode, we review a randomized, placebo-controlled clinical trial that explores how semaglutide may influence taste perception
Semaglutide Linked to Rare Brain Illness
In rare cases, semaglutide for obesity is linked to Wernicke encephalopathy, driven by gastrointestinal intolerance, reduced nutritional int
GLP-1 Receptor Agonists and Eye Safety: Examining the NAION Risk at ADA 2025
Do their associations with nonarteritic anterior ischemic optic neuropathy and other adverse outcomes make these drugs more risky than benef
mdsc.pe·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.